A Study to Evaluate the Tolerability, Safety and Pharmacokinetic Characteristics of DA-3803

NCT01851512 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
27
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Dong-A Pharmaceutical Co., Ltd.